22 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) rose 23.7% to $3.18 in pre-market trading after jumping 10% on Monday. The company, last month, priced its IPO at $10 per unit.
Co-Diagnostics Stock Sees Movement After Company Says Products Unaffected By Omicron Variant
Co-Diagnostics Inc. (NASDAQ: CODX) shares gapped higher Monday, but have since fallen and are now trading lower.
70 Biggest Movers From Friday
Gainers
Everspin Technologies, Inc. (NASDAQ: MRAM) shares surged 63.2% to close at $10.74 on Friday after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.
18 Stocks Moving In Friday’s Pre-Market Session
Gainers
NuZee, Inc. (NASDAQ: NUZE) rose 30.3% to $6.89 in pre-market trading after jumping around 165% on Thursday. NuZee manufacturing partner, Cuvee Coffee, reported an expansion into select Walmart stores nationwide.
HC Wainwright & Co. Maintains Buy on Co-Diagnostics, Lowers Price Target to $15
HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Buy and lowers the price target from $16 to $15.
Earnings Scheduled For November 11, 2021
Companies Reporting Before The Bell
• NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million.
Co-Diagnostics, Inc. Logix Smart COVID-19 2-Gene Test Approved For Use In The United Kingdom
Co-Diagnostics, Inc. (NASDAQ:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ SARS-CoV-2 2-Gene multiplex test
Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for Dengue/Chikungunya Multiplex Test
Co-Diagnostics, Inc.(NASDAQ:CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt